A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal CancerChristopher G. Willett, Dan G. Duda, Gregory Y. Lauwers et al.|The Oncologist|2010Cited by 54